PVLA
PVLA
NASDAQ · Biotechnology

Palvella Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$126.84
-1.48 (-1.15%)
As of May 9, 1:39 AM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 21 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -58.4% upside
Low Target $42.56
Average Target $52.81
High Target $76.13
Current Price $126.84
Current
$126.84
Target
$52.81
$42.56 $52.81 avg $76.13
Scenario Analysis
Bear Case
$42.56
-66.4%
Low target
Base Case
$52.81
-58.4%
Avg target
Bull Case
$76.13
+-40.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$151.18
-16.1% from high
52-Week Low
$20.20
+527.9% from low
Target vs 52W High
$52.81
-65.1% vs high
Next Earnings Report
May 14, 2026
3d
until earnings
EPS Est: $-0.95
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%